{"filings":[{"id":945636,"accession_number":"0001568651-26-000059","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-06-09T20:11:37+00:00","items":["5.07"],"status":"ready","headline":"Oscar Health elects 8 directors, approves say-on-pay and auditor at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All eight director nominees elected with votes FOR ranging from 750M to 773M; broker non-votes ~46M.","Advisory vote on named executive officer compensation passed: 765M FOR, 8.9M AGAINST, 330K abstain.","Ratification of PricewaterhouseCoopers as auditor for 2026 approved: 819M FOR, 710K AGAINST, 126K abstain.","Quorum of 820,307,497 votes represented; Class B shares carry 20 votes each."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":899877,"accession_number":"0001568651-26-000054","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-06-08T10:29:50+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health to present at Goldman Sachs conference, reaffirms FY2026 guidance","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Fireside chat at Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026 at 11:20 AM ET.","Company plans to reaffirm full year 2026 guidance originally provided on February 10, 2026.","Live audio webcast available on ir.hioscar.com; replay for 90 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":787196,"accession_number":"0001568651-26-000048","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-06-02T10:31:58+00:00","items":["5.02"],"status":"ready","headline":"Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["New role as Co-Founder & Advisor to CEO effective June 1, 2026; continues to serve on Board.","Annual base salary set at $370,000; no longer eligible for annual bonus starting 2026.","Will not receive future equity awards; existing equity continues to vest per original terms.","No cash severance or subsidized healthcare upon termination of employment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93738,"accession_number":"0001568651-26-000036","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q1 net income $679M ($2.07 EPS) vs $275M ($0.92) YoY; revenue $4.65B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.65B, up 53% YoY from $3.05B; net income $679M ($2.07 EPS) vs $275M ($0.92 EPS) YoY.","Medical loss ratio improved to 70.5% from 75.4% YoY; SG&A ratio 15.2% from 15.8%.","Membership increased to ~3.17M from ~2.04M, up 55% YoY.","Adjusted EBITDA $727M vs $329M YoY; Company reaffirms full-year 2026 guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":2.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":4647194000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93737,"accession_number":"0001568651-26-000028","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Oscar Health appoints new Board Chair, Siddhartha Sankaran, effective June 4","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Siddhartha Sankaran appointed independent Chair of Board, effective June 4, 2026.","Succeeds Jeffery Boyd, who served as Chair since Feb 2021 and is not standing for reelection.","Sankaran has over 20 years insurance experience, including executive roles at AIG, SiriusPoint, FWD Group.","CEO Mark Bertolini expressed confidence in Sankaran leading Board through next phase of growth.","Boyd's tenure included Oscar's IPO and transformation from startup to individual market leader."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105603,"accession_number":"0001568651-26-000014","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reaffirms FY 2026 guidance at Raymond James conference","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Participating in the 2026 Raymond James Institutional Investors Conference on March 2, 2026.","Reaffirming full-year 2026 guidance previously announced on Feb 10, 2026 in Q4/FY2025 earnings release.","No new financial metrics or changes to prior guidance disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105602,"accession_number":"0001568651-26-000008","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["1.01","2.02","2.03","9.01"],"status":"ready","headline":"Oscar Health reports record 3.4M members, FY2025 net loss $443M; guides FY2026 revenue $18.7-$19B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2025 net loss $443.2M ($1.69 diluted EPS) vs prior-year net income $25.4M ($0.10 diluted EPS).","Record membership of ~3.4 million as of Dec 31, 2025, up from 1.68 million a year earlier.","FY2025 total revenue $11.7B (up 27% YoY); medical loss ratio 87.4% (vs 81.7% in 2024).","FY2026 guidance: revenue $18.7-$19.0B, MLR 82.4-83.4%, SG&A ratio 15.8-16.3%, operating earnings $250-$450M.","Entered into $475M secured three-year revolving credit facility (Feb 6, 2026) for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":11701427000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121887,"accession_number":"0001193125-25-335294","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-12-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Oscar Health amends CEO Bertolini's employment agreement; $45M equity grant, base salary $1.3M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["New term from Dec 22, 2025 to Apr 1, 2029, with automatic one-year renewals unless either party elects not to extend.","Annual base salary set at $1.3M; target bonus increased to 150% of base starting in 2026.","$45M in RSU awards granted Q1 2026: 50% time-vesting over three years, 50% performance-based.","Enhanced severance: 1.5x cash multiplier and 18 months of healthcare upon without-cause or good reason termination.","Mr. Bertolini not eligible for other long-term equity awards until calendar year 2029."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121886,"accession_number":"0001568651-25-000035","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Oscar Health Q3 net loss $137.5M ($0.53 EPS); exchanges $187.5M notes for 23.3M shares","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue $2.99B (+23% YoY); net loss $137.5M vs $54.6M loss YoY; Adj EBITDA loss $101.5M vs $11.6M loss.","Medical loss ratio 88.5% (vs 84.6% YoY) driven by $130M increase in risk adjustment accrual; SG&A ratio improved to 17.5%.","Reaffirmed FY2025 guidance: revenue $12.0-12.2B, loss from operations $200-300M, MLR 86-87%.","On Nov 5, exchanged $187.5M of 7.25% convertible notes due 2031 for 23.3M shares; up to $62.5M more by Dec 14.","Debt covenants extinguished; $410M subordinated notes due 2030 no longer subordinated to 2031 notes."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":8896192000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138578,"accession_number":"0001193125-25-207417","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Oscar Health issues $410M of 2.25% convertible notes due 2030; net proceeds ~$395.8M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Notes carry 2.25% coupon, mature Sep 1, 2030; initial conversion price ~$24.82 per share.","Net proceeds of ~$395.8M used $34.4M for capped calls; balance for AI, care cost reduction, growth.","Initial purchasers fully exercised $55M option; capped calls cap price $37.46 per share.","Notes subordinated to senior debt; structurally subordinated to subsidiary liabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138577,"accession_number":"0001193125-25-204231","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["1.02","8.01","9.01"],"status":"ready","headline":"Oscar Health prices $355M 2.25% convertible notes due 2030; uses proceeds for growth and AI","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Upsized offering of $355M (from $350M); 2.25% interest, due September 1, 2030.","Net proceeds ~$342.5M (or ~$395.8M if initial purchasers exercise $55M option).","Initial conversion price $24.82/share, a 32.5% premium to $18.73 closing price.","Capped call transactions with cap at $37.46/share (100% premium) to reduce dilution.","Will terminate revolving credit facility contingent on closing of the offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138576,"accession_number":"0001193125-25-203549","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Oscar Health proposes $350M convertible notes due 2030; to fund AI, growth initiatives","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$350M principal amount of convertible senior subordinated notes due 2030; underwriters option for additional $52.5M.","Net proceeds for general corporate purposes, including AI initiatives, lowering cost of care, and potential extension of enhanced premium tax credits.","Notes subordinated to senior debt; interest rate and conversion price set at pricing; redeemable after Sep 2028 if stock exceeds 130% conversion price.","Expects to enter capped call transactions to offset dilution upon conversion; counterparties may hedge affecting stock price.","Plans to terminate revolving credit facility with Wells Fargo upon closing of the offering; amendment with Dragoneer permits offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138575,"accession_number":"0001193125-25-194448","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reaffirms FY2025 guidance at Wells Fargo conference","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reaffirmed updated full-year 2025 guidance first provided July 22, 2025.","Participating in 2025 Wells Fargo Healthcare Conference on September 3, 2025.","No new financial information or changes to outlook disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138574,"accession_number":"0001568651-25-000021","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q2 net loss $228.4M, MLR 91.1% vs 79.0% YoY; revenue up 29%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue: $2.86B, up 29% YoY from $2.22B on higher membership, partly offset by risk adjustment accrual.","Medical loss ratio worsened to 91.1% from 79.0%, driven by higher market morbidity and net risk adjustment accrual.","Net loss attributable to Oscar of $228.4M ($0.89 per diluted share) vs net income of $56.2M ($0.20) in Q2 2024.","Adjusted EBITDA loss $199.4M, compared to positive $104.1M a year ago; SG&A ratio improved to 18.7% from 19.6%.","Reaffirmed full-year 2025 outlook; membership grew 28% to 2.03M; Cigna+Oscar members fell from 58k to 10k."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":5910208000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138573,"accession_number":"0001568651-25-000018","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health expects Q2 operating loss ~$230M; cuts FY2025 guidance on higher ACA risk scores","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 expects loss from operations of ~$230M and net loss of ~$228M.","FY2025 guidance revised: Total Revenue $12.0B-$12.2B, MLR 86-87%, Operating loss ($300M)-($200M).","Cost trends moderated vs Q1 but utilization remains elevated; plans 2026 rate resubmissions covering ~98% of membership.","2024 risk adjustment results $23M favorable to prior accruals.","Adjusted EBITDA expected to be ~$120M better than operating loss."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":5910208000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":156024,"accession_number":"0001193125-25-137039","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Oscar Health stockholders elect nine directors, ratify auditor, approve say-on-pay at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected; highest vote FOR Mark T. Bertolini (804M), lowest Mario Schlosser (799M).","Ratification of PricewaterhouseCoopers as auditor for FY2025: 825,271,165 FOR, 581,597 against.","Advisory vote on executive compensation approved: 801,338,734 FOR, 3,246,195 against.","Quorum achieved with 825,961,296 votes cast out of 929,277,354 available."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":156023,"accession_number":"0001568651-25-000012","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health reports Q1 2025 revenue of $3.05B, net income $275M, and reaffirms full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue rose 42% year-over-year to $3.046 billion for Q1 2025, driven by higher membership.","Net income attributable to Oscar Health grew to $275.3 million ($0.92 per diluted share) from $177.4 million.","Adjusted EBITDA increased to $328.8 million, up from $219.3 million in the prior-year quarter.","Membership reached 2,039,467 effectuated members, a 41% increase compared to Q1 2024.","Company reaffirms full-year 2025 outlook across all metrics as previously provided on February 4, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":3046263000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174490,"accession_number":"0001193125-25-043364","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reaffirms FY2025 guidance at Raymond James conference","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company participates in 2025 Raymond James Institutional Investors Conference on March 3.","Reaffirms full year 2025 guidance originally provided on Feb 4, 2025 in Q4 2024 earnings release.","No new financial information or changes disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174489,"accession_number":"0001568651-25-000005","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Oscar Health reports first-ever positive net income of $25.4M in 2024; appoints new insurance president","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total Revenue $9.2B (+56.5% YoY); Net income $25.4M ($0.10 diluted EPS) vs loss of $270.7M in 2023.","Adjusted EBITDA $199.2M, a $244.5M improvement YoY, marking first year of profitability on this metric.","2025 guidance: Revenue $11.2-11.3B, MLR 80.7-81.7%, SG&A 17.6-18.1%, Earnings from Operations $225-275M.","Janet Liang appointed EVP & President of Oscar Insurance, effective Feb 24, 2025; COO Steven Wolin resigned.","Membership grew to 1.68M (+62% YoY); Individual & Small Group members 1.64M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":9177564000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191446,"accession_number":"0001568651-24-000029","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q3 revenue $2.4B (+68% YoY); narrows loss; raises FY revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $2.4B, +68% YoY; net loss $54.6M ($0.22 EPS) improved $10.8M YoY.","Membership grew to 1.65M from 983k YoY, driven by Individual and Small Group (1.60M).","Adjusted EBITDA loss $11.6M, improved $8.7M YoY; SG&A expense ratio improved to 19.0% from 22.6%.","FY2024 revenue guidance raised to $9.2-9.3B; expects net income profitability this year.","Medical Loss Ratio 84.6%, up 80bps YoY due to higher medical costs and risk adjustment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":6785128000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207924,"accession_number":"0001193125-24-212607","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-09-04T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health to reaffirm FY2024 guidance at three investor conferences in Sept 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company participates in Wells Fargo Conference Sept 4, Morgan Stanley Conference Sept 5, and Baird Conference Sept 11.","Management will reaffirm the updated full-year 2024 guidance from the Q2 2024 earnings release (Aug 7, 2024).","Presentations webcast; access details on ir.hioscar.com investor relations page."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207923,"accession_number":"0001568651-24-000021","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q2 net income $56.2M, rev $2.2B +46% YoY, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $56.2M ($0.20 diluted EPS) vs. loss of $15.5M a year ago.","Total revenue $2.2B, up 46% YoY driven by higher membership and rate increases.","Adjusted EBITDA $104.1M, up from $35.6M in Q2 2023; MLR improved 90bps to 79.0%.","Raised FY 2024 revenue guidance to $9.0-9.1B (prior $8.3-8.4B) and Adj EBITDA to $160-210M (prior $125-175M).","Total membership 1.58M, up 63% YoY, driven by Individual & Small Group growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":4361646000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225425,"accession_number":"0001193125-24-159132","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Oscar Health holds 2024 Annual Meeting; all director nominees and proposals approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ten director nominees elected; top vote getter Mark T. Bertolini with 840.4M votes for.","Ratification of PwC as auditor for FY2024 approved with 861.7M votes for.","Advisory say-on-pay proposal approved with 790.9M votes for (91.7% of votes cast).","Quorum of 862.2M votes out of 911.8M total votes represented."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225424,"accession_number":"0001193125-24-156438","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reconfirms FY2024 guidance, to provide updated strategic targets at Investor Day","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Reaffirms full-year 2024 guidance as provided in Q4 2023 earnings release dated Feb 7, 2024.","Will update on Adjusted EBITDA performance through April 30, 2024.","To discuss long-term growth targets and strategic levers at June 7 Investor Day."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225423,"accession_number":"0001568651-24-000013","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health reports first-ever quarterly net income of $177.4M; revenue up 46% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2024 net income of $177.4M ($0.62 diluted EPS) vs. net loss of $39.8M in Q1 2023.","Total revenue of $2.1B, up 46% YoY driven by higher membership and pricing.","Medical Loss Ratio improved 210 bps YoY to 74.2%; SG&A Expense Ratio improved 870 bps to 18.4%.","Adjusted EBITDA of $219.3M, up $168.2M YoY; total members reached 1,448,408.","Company reaffirms full-year 2024 outlook across all metrics."],"consensus_eps_estimate":null,"consensus_eps_actual":0.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":2142305000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244609,"accession_number":"0001568651-24-000004","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-02-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health posts FY2023 net loss $271M; 2024 adjusted EBITDA guidance positive $125M-$175M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2023 Direct and Assumed Policy Premiums $6.6B (-3% YoY); Premiums earned $5.7B (+47% YoY).","Medical Loss Ratio improved 370 bps to 81.6%; InsuranceCo Combined Ratio 99.5% (640 bps improvement).","Net loss $271M improved $339M YoY; Adjusted EBITDA loss $45M improved $417M YoY.","Membership 1,036,283 as of Dec 31, 2023, down from 1,151,483 a year ago.","2024 guidance: Total Revenue $8.3B-$8.4B; MLR 80.2%-81.2%; Adj. EBITDA $125M-$175M (positive)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":5862869000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244608,"accession_number":"0001193125-24-005574","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-01-10T23:59:59+00:00","items":["2.02"],"status":"ready","headline":"Oscar Health reaffirms FY2023 guidance and 2024 EBITDA target; no new figures","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Reaffirms full year 2023 guidance as provided in Q3 2023 earnings release (Nov 7, 2023).","Reaffirms target for Total Company Adjusted EBITDA profitability in 2024.","To provide interim membership update from 2024 open enrollment at JPM conference.","No specific financial results or new numbers disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":262047,"accession_number":"0001193125-23-305664","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-12-29T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Oscar Health amends credit facility; maturity extended to Dec 2025, commitments cut to $115M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Third Amendment to Credit Agreement dated Dec 28, 2023 extends revolving loan maturity to Dec 28, 2025.","Total revolving commitments reduced to $115M from prior level; option to increase by up to $50M subject to conditions.","Floating interest rate unchanged: SOFR + 4.50% or base rate + 3.50%.","New financial covenants include minimum direct premiums per quarter, maximum medical loss ratio, minimum adjusted EBITDA, and minimum liquidity thresholds.","Bank of America assigned its commitments to Blue Ridge Investments, L.L.C. effective immediately before the amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":262046,"accession_number":"0001193125-23-280184","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-11-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Deerfield and CEO Bertolini's foundation to buy 5M shares from selling shareholder","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Deerfield will purchase 3,000,000 shares of Oscar Class A common stock.","Anahata Foundation (CEO Mark Bertolini's charity) will purchase 2,000,000 shares.","Closing expected on or about November 22, 2023, subject to customary conditions.","Oscar is not a party to the Stock Purchase Agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":262045,"accession_number":"0001568651-23-000054","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q3 net loss narrows to $65.7M; raises 2023 EBITDA outlook; new +Oscar deal","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $65.7M vs $193.5M loss YoY; Adjusted EBITDA loss of $20.3M vs $159.8M loss YoY.","Medical Loss Ratio improved 608 bps to 83.8%; InsuranceCo Combined Ratio improved 934 bps to 101.3%.","Raises 2023 InsuranceCo Adj EBITDA guidance to $155M-$165M (from $20M-$120M); consolidated Adj EBITDA loss to ($60M)-($50M).","New multi-year +Oscar agreement with Sanford Health Plan for member engagement technology.","Direct and Assumed Policy Premiums $1.6B, down 5% YoY; Premiums earned $1.4B, up 46% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":4431211000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279249,"accession_number":"0001193125-23-231903","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-09-11T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health CEO to present at Morgan Stanley conference; reaffirms FY2023 outlook","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["CEO Mark T. Bertolini to present at Morgan Stanley 21st Annual Global Healthcare Conference on Sept 11, 2023.","Company expected to reaffirm full-year 2023 outlook across all metrics as provided in Q2 2023 earnings release dated Aug 8, 2023.","Presentation will be webcast; replay available for 90 days on ir.hioscar.com.","No new financial guidance or business metrics disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279248,"accession_number":"0001568651-23-000043","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Oscar Health Q2 2023: net loss narrows to $15.4M; Adj EBITDA turns positive at $35.6M; CFO Blackley appointed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $15.4M improved $96.7M YoY; Adjusted EBITDA $35.6M vs -$75.8M YoY.","MLR improved 230 bps YoY to 79.9%; InsuranceCo Combined Ratio improved 500 bps to 96.7%.","Premiums earned $1.5B (+48% YoY); Direct and Assumed Policy Premiums $1.6B (-3% YoY).","Full-year 2023 guidance tightened: MLR towards low-end of 82-84%, Adj EBITDA towards high-end of -$175M to -$75M.","R. Scott Blackley returns as CFO effective Aug 14; Sid Sankaran steps down but stays on Board."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":2991220000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":297603,"accession_number":"0001193125-23-166046","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-06-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Oscar Health 2023 annual meeting results: all director nominees elected, auditor ratified, say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ten director nominees elected; each received >720M votes FOR, broker non-votes ~32M.","Ratification of PricewaterhouseCoopers as auditor: 784.9M FOR, 691K AGAINST, 66K abstain.","Advisory vote on executive compensation: 752.9M FOR, 668K AGAINST, 102K abstain; broker non-votes ~32M.","Quorum of 785.7M votes out of 885.5M total available votes present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":297602,"accession_number":"0001193125-23-156580","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-05-30T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Interim CFO Sankaran to exit Aug 31; Oscar Health reaffirms 2023 outlook","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Siddhartha Sankaran will step down as interim CFO on Aug 31, 2023 after Q2 Form 10-Q filing.","Sankaran remains on Oscar Health's board of directors after the transition.","Departure due to internationally based executive role requiring regulatory pre-approval.","Company is seeking a permanent CFO and expects to name a successor before Aug 31.","Reaffirmed full-year 2023 guidance and profitability targets as provided on Feb 9, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":297601,"accession_number":"0001568651-23-000026","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q1 net loss narrows to $39.6M; adjusted EBITDA turns positive at $51.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Premiums earned up 50% YoY to $1.4B; Direct & Assumed Policy Premiums $1.7B (+2% YoY).","Medical Loss Ratio improved 108 bps YoY to 76.3%; InsuranceCo Combined Ratio 94.9% (+230 bps).","Adjusted EBITDA of $51.1M vs. -$37.0M in prior year; net loss improved $37.7M YoY to -$39.6M.","FY2023 outlook reaffirmed: MLR 82-84%, Adj EBITDA loss of -$175M to -$75M.","Membership at 1.02M (down 5% YoY) but Cigna+Oscar partnership grew to 67K members."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":1469685000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317889,"accession_number":"0001193125-23-081327","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-03-28T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Oscar Health appoints Mark Bertolini CEO; Schlosser moves to President of Technology","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mark Bertolini (ex-Aetna CEO) becomes CEO and board member effective April 3, 2023; Mario Schlosser transitions to President of Technology.","Bertolini receives sign-on equity of 10.32M shares: 2.87M time-vested RSUs and 7.45M performance-vested PSUs with price targets of $11, $16, $39.","Founders Schlosser and Kushner cancel their PSU awards (total 6.34M shares), triggering a ~$46M non-cash charge in Q1 2023.","Inducement plan authorized shares increased from 5M to 18.32M to accommodate Bertolini's grants and annual employee awards.","Company reaffirms full-year 2023 guidance as originally issued on February 9, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317888,"accession_number":"0001193125-23-067865","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-03-13T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health discloses no deposits, investments, or debt at failed Silicon Valley Bank","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Oscar Health confirms it holds no deposits at Silicon Valley Bank (SVB).","No direct investments in SVB or debt arrangements with SVB.","Disclosure made on March 10, 2023, following FDIC seizure of SVB."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317887,"accession_number":"0001568651-23-000006","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-02-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Oscar Health reports FY 2022 net loss $610M; guides 2023 to near breakeven adjusted EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2022 premiums earned $3.9B, up 111% YoY; Direct & Assumed Policy Premiums $6.8B, up 99%.","Membership reached 1,151,483 as of Dec 31, 2022, a 93% increase YoY, led by Individual & Small Group.","Medical Loss Ratio improved 360 bps to 85.3%; InsuranceCo Combined Ratio improved 490 bps to 105.8%.","2023 outlook: Direct & Assumed Policy Premiums $6.4B-$6.6B, InsuranceCo Combined Ratio ≤100%.","Guides FY 2023 Adjusted EBITDA loss of ($175M)-($75M), significantly improved from ($462M) in 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":3963638000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317886,"accession_number":"0001193125-23-004172","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2023-01-09T23:59:59+00:00","items":["2.02"],"status":"ready","headline":"Oscar Health reaffirms FY2022 guidance, 2023 profitability target at JPM Conference","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Reaffirms full-year 2022 guidance per Nov 8, 2022 press release.","Reaffirms 2023 profitability target for InsuranceCo.","Provides interim membership update from 2023 open enrollment.","Presentation at 41st JPM Healthcare Conference on Jan 11, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":336155,"accession_number":"0001193125-22-303886","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-12-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Oscar Health director Charles E. Phillips Jr. resigns effective Dec 31, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Charles E. Phillips Jr. notified the board on Dec 7, 2022 of his resignation.","Resignation effective December 31, 2022, due to his appointment to a Federal advisory board.","Company states resignation is not due to any disagreement with its operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":336154,"accession_number":"0001193125-22-299814","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-12-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Oscar Health expands board to 10, appoints Laura Lang and Bill Gassen as independent directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size expanded from 8 to 10; appointments effective December 7, 2022.","Laura Lang appointed as Chair of Compensation Committee; Bill Gassen joins Nominating Committee.","Both independent under NYSE rules; Gassen is president/CEO of Sanford Health.","Lang served as CEO of Time Inc. and Digitas; also on boards of VF Corp and Vroom.","Standard director compensation: $70k annual cash retainer, $175k initial RSU grant, $175k annual RSU."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":336153,"accession_number":"0001568651-22-000054","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-11-08T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Oscar Health Q3: Net loss $194M, membership up 81%; CFO transition announced, targets 2024 profitability","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Membership of 1,075,445 as of Sep 30, 2022, up 81% YoY; premiums earned $954M, up 116% YoY.","Net loss of $194M improved $18M YoY; Adjusted EBITDA loss of $160M improved $28M YoY.","Medical Loss Ratio improved 980 bps to 89.9%; InsuranceCo Combined Ratio improved 1,220 bps to 110.6%.","FY2022 guidance updated: Direct and Assumed Policy Premiums $6.7-6.9B; Adjusted EBITDA loss modestly above $480M high-end.","CFO R. Scott Blackley transitions to Chief Transformation Officer; Sid Sankaran returns as Interim CFO effective Dec 1, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.8,"consensus_revenue_estimate":null,"consensus_revenue_actual":2968511000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353588,"accession_number":"0001193125-22-240450","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-09-08T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health to reaffirm FY2022 guidance at two healthcare conferences","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company will present at Wells Fargo Healthcare Conference on Sep 8 and Morgan Stanley Global Healthcare Conference on Sep 12.","Will reaffirm full year 2022 guidance as originally issued Feb 10, 2022 and reaffirmed Aug 11, 2022.","Webcasts available via investor relations page (ir.hioscar.com); details previously provided Sep 1, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353587,"accession_number":"0001193125-22-234113","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-08-30T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health announces termination of services agreement with Health First effective Jan 1, 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Health First intends to terminate agreement with Oscar Health's +Oscar business, effective as early as Jan 1, 2023.","Services expected to continue through at least Dec 31, 2022; 2022 admin services revenue estimated at $55-60M.","Impact on 2022 Adjusted EBITDA and net loss expected to be immaterial.","Company continues developing +Oscar's Campaign Builder and focusing on modular SaaS offerings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353586,"accession_number":"0001568651-22-000036","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-08-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Oscar Health Q2 2022: revenue up 88% YoY to $995M, net loss widens to $112M; reaffirms FY22 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Membership 1,036,720 (+84% YoY); Direct & Assumed Premiums $1.7B (+101%).","Premiums earned $995M (+88%); MLR 82.2% (down 20 bps YoY).","Net loss $112M (vs $73M loss in Q2'21); Adj. EBITDA loss $76M (vs $51M).","InsuranceCo Combined Ratio improved 50 bps YoY to 101.7%.","Reaffirmed 2022 guidance: Direct Premiums $6.1-6.4B, MLR 84-86%, Adj. EBITDA loss $480-380M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":1990084000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371315,"accession_number":"0001193125-22-173830","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-06-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Oscar Health shareholders elect eight directors, ratify auditor, back annual say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected with >728M votes FOR each; broker non-votes 45M.","Ratification of PwC as auditor for FY2022: 779M FOR, 276K AGAINST.","Advisory vote on pay frequency: 734M votes for 1 year; Board adopts annual say-on-pay.","Total votes cast: 779.8M out of 878.2M available; quorum achieved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371314,"accession_number":"0001568651-22-000019","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Oscar Health Q1 membership up 98% to 1.07M; net loss narrows to $77M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Direct and Assumed Policy Premiums $1.68B (+104% YoY); Premiums earned $955M (+159% YoY).","Medical Loss Ratio 77.4% (up 300 bps YoY); InsuranceCo Combined Ratio 97.2% (up 300 bps).","Net loss of $77M improved $12M YoY; Adjusted EBITDA loss $37M worsened $9M YoY.","Adjusted Administrative Expense Ratio improved 220 bps to 23.8% on operating leverage.","Reaffirmed FY2022 outlook: DAPP $6.1-6.4B, MLR 84-86%, Adj. EBITDA loss $380-480M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":972765000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371313,"accession_number":"0001193125-22-101705","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-04-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Teri List resigns from Oscar Health board; Vanessa Wittman appointed Audit Committee Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Teri List resigned effective April 8, 2022, to pursue another board opportunity; no disagreement with the company.","Vanessa A. Wittman, an independent director, appointed to Audit Committee effective April 8, 2022.","Wittman replaces List as Audit Committee Chair; Wittman has CFO experience at multiple tech companies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":390303,"accession_number":"0001193125-22-084000","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-03-24T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health to host virtual investor day on March 25, reaffirming FY2022 guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Investor day scheduled for March 25, 2022, at 9:00 a.m. ET; live webcast on IR website.","Company will reconfirm full-year 2022 guidance from its Feb 10, 2022 earnings release.","Presentation materials will be posted on IR website shortly before the conference begins.","Event is virtual and accessible via https://ir.hioscar.com."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":390302,"accession_number":"0001193125-22-069866","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2022-03-09T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reaffirms FY2022 guidance at Cowen conference","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company reconfirms full-year 2022 guidance issued on Feb 10, 2022; no new financial metrics provided.","Virtual presentation at Cowen 42nd Annual Health Care Conference on March 9, 2022 at 9:50 AM ET.","Guidance covers revenue, membership, and adjusted EBITDA as previously disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-03-09T23:59:59+00:00|390302"}